推进药物开发以预防自发早产
Christina Chang1, Cameron Joyce2, Mia Williams2
1Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA.
Journal of neonatal-perinatal medicine
|January 12, 2026
概括
早产预防疗法面临的发展障碍是由于有限的PTB理解和试验挑战. 建议包括基础科学研究,改进数据和监管灵活性,以推进新疗法.
科学领域:
- 产科和妇科 产科和妇科
- 药理学和治疗学 药理学和治疗学
- 公共卫生政策 公共卫生政策
背景情况:
- 过早分娩 (PTB) 影响美国每10个怀孕中就有1个,导致婴儿患病率和死亡率显著.
- 取消Makena (基孕甲酸盐) 在FDA批准的治疗中留下了一个关键的缺口,用于复发性自发性PTB.
- 对PTB原因的理解有限,缺乏有效的治疗方法阻碍了临床实践.
研究的目的:
- 总结公开研讨会上的讨论,讨论PTB预防药物开发的挑战和机遇.
- 确定关键障碍和潜在解决方案,以推进预防自发早产 (sPTB) 的治疗方法.
主要方法:
- 一个由FDA-Duke Margolis卫生政策研究所在2024年1月召开的公共研讨会.
- 讨论涉及研究人员,临床医生,行业代表,患者倡导者和监管机构.
- 关键主题包括PTB病因学,试验设计,结果措施,资金和监管途径.
主要成果:
- 发现的挑战包括对PTB原因的理解不足,试验中的伦理考虑,以及对结果措施缺乏共识.
- 建议强调对PTB机制的基础科学研究,改善数据质量和妊娠年龄特定的终点.
- 加速发展的战略包括监管灵活性,创新的试验设计,增强资金和数据共享.
结论:
- 推进PTB预防需要采取多方面的方法,解决科学知识差距和发展挑战.
- 合作努力和战略投资对于降低早期研究风险和将发现转化为有效疗法至关重要.
- 改进的监管途径和创新的试验设计可以促进开发急需的PTB治疗方法.
相关概念视频
01:28Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
01:30Preventive Healthcare Services
1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
01:29Drug Dosing: Infants and Children
248
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
248
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
01:26Levels of Health Promotion and Illness Prevention
14.2K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
14.2K
01:26Drug Administration and Therapy Phases: Overview
1.2K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.2K